Drug Type ASO |
Synonyms |
Target |
Mechanism IGF-1R antagonists(Insulin-like growth factor I receptor antagonists), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ImVax, Inc.Startup |
Active Organization ImVax, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometrial Carcinoma | Preclinical | US | ImVax, Inc.Startup | - |